On March 5, 2019, FDA Commissioner Scott Gottlieb, M.D. and FDA/CFSAN Director, Susan Mayne, Ph.D., released new independent test results confirming asbestos contamination in certain cosmetic products sold by Claire’s and Justice retailers.  The agency also issued a safety alert warning consumers not to use the cosmetic products sold by Claire’s that had tested positive

Social media is a powerful marketing tool. It’s personal, dynamic, and reaches an unlimited number of consumers. But, the value of social media can be tempered by the legal risks. Both the Federal Trade Commission and the Food and Drug Administration have been paying close attention to social media activities by dietary supplement companies and

United States District Judge Phyllis Hamilton has denied a request from the FDA for additional time to promulgate standards for preventing intentional adulteration of food, stating that although she is sympathetic to the FDA’s position, “the dispute here is between the FDA and Congress.”

The order is the latest development stemming from an August 2012

According to the 2013 unified agenda for the Department of Health and Human Services, FDA plans to recommend several changes to U.S. OTC drug labeling, safety monitoring, and manufacturing standards in 2013 which may impact future marketing and product development strategies for consumer products. Forthcoming FDA proposals include the following:

 Proposed Monograph Modifications

  •  Amending

On February 28, 2012, the U.S. Department of Agriculture (USDA), Food Safety and Inspection Service (FSIS) issued a notice entitled “Verifying Nutrition Labeling for the Major Cuts of Single-Ingredient, Raw Meat and Poultry Products and Ground or Chopped Meat and Poultry Products.”  The notice provides instructions to inspection program personnel (IPP), Import Inspection